APC member Jennifer Burch (owner of Central Compounding Center, Durham, NC) and APC CEO Scott Brunner recently did their part to clear the confusion regarding compounded hormone therapy and enhance awareness of its many benefits.
*By "win BIG" we mean that the knowledge you gain will help you be the best gosh darn compounding pharmacist you can be.
Assure your team has the current expertise it needs to practice with high competence and integrity by joining us for EduCon 2023 Virtual: Best Practices in Compounding.
It’s been two years since we started talking about FDA’s implicit threat to restrict compounded hormones. So far, the agency has done nothing. But "nothing" is a good thing.
FDA representatives have agreed to meet on Nov 9 with APC and other pharmacy organization leaders about FDA’s recent apparent reclassification of desiccated thyroid extract (DTE) as a biologic.
On December 14, FDA is hosting a webinar, "What to Expect after an Inspection: 483s, Responses and Beyond."
The pre-enforcement period was originally scheduled to end on October 27, 2022.
FOLLOW US
